Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)

Infarction, Myocardial Clinical Trial

Official title:
Eptifibatide Versus Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction

Status Completed

Clinical Trial Summary

Multinational, multicentre, randomised, prospective, open, parallel group study directly comparing two glycoprotein-IIb/IIIa inhibitors, abciximab and eptifibatide, added early to standard treatment before primary PCI of STEMI patients with respect to effect on sum-ST-resolution after 60 minutes post-procedure and other measures of myocardial reperfusion

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00426751
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 3
Start date	October 2006
Completion date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00196274` - Autonomic Regulation Trial (ART)	N/A
Recruiting	`NCT04000412` - A Novel Myocardial Impedance Mapping System for Ablation of Post-infarction Ventricular Arrhytmias in Humans
Completed	`NCT03122210` - Comparaison of 2 SpO2 Level Measured by Pulse Oxymetry in Complications of Acute Coronary Syndrome.	N/A
Completed	`NCT00196261` - Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction	N/A
Completed	`NCT04096079` - Post-ROSC Electrocardiogram After Cardiac arrEst
Completed	`NCT05123885` - Wearable Then Implantable Cardiac Defibrillator After Myocardial Infarction